BOZEN, Sud-Tirol, Italy, May 17, 2011 /PRNewswire/ -- Health Robotics
today announced the company's 2011 Annual Scientific Advisory Board (SAC)
Meeting, jointly hosted this week by Campus BioMedico University Hospital
facilities in Rome and Health Robotics' Research & Development Center in
Trieste, Friuli-Venezia Giulia Region, Italy.
"Under the leadership of Fabio Fioravanti, Health Robotics' Chief Technical Officer, the SAC launches to a great start in 2011. We are all very grateful to Campus BioMedico University Hospital for hosting their SAC colleagues this year, and showcasing Health Robotics' products to the rest of SAC Board Members from University of Chicago, Ochsner Clinic, USC University Hospital, Sutter Health, Grifols, and Bolzano General Hospital, and finally to all of the participants in this week's events. Amongst the SAC highlights include the scientific review of gravimetric control processes, USP797 and cGMP regulations, negative and positive pressure chambers for robotic IV compounding, accuracy of QS doses, prevention of cross-contamination, and finally "hands-on" and peer-reviewed sessions on CytoCare, i.v.STATION, i.v.SOFT, i.v.STATION ONCO, and TPNstation," stated Gaspar DeViedma, Health Robotics' Executive Vice President.
The role of the Scientific Advisory Board is to assist Health Robotics' Research and Development efforts to complete its revolutionary I.V. Room of the Future concept: a "Patient-Aware, All-Digital" construct depicting a common visual and operational framework that elevates the overall understanding of the patients' I.V. Medication needs - its clinical, logistics, quality, costs, and procedural structures; the real-time tracking of I.V. Medications across the care continuum; the optimization of robotics and software automation tools to bridge the gap between rising patient volume/acuity and scarce pharmacy personnel resources; and finally the procedural discipline through visible steps and/or check-points that ensure that critical steps are taken, quality procedures are followed, and audit trails are generated as a by-product of the IV Admixture process.
About Health Robotics:
Founded in 2006, Health Robotics is the undisputed global leading supplier of life-critical intravenous medication robots, providing over 180 hospital installations in 6 continents with robotics-based technology and software automation solutions deployed utilizing virtual high-availability technology. Its world-leading solutions CytoCare(R) and i.v.STATION(R) ONCO [hazardous IVs], i.v.STATION(R) [non-hazardous IVs], i.v.SOFT(R) [workflow engine for manual compounding], MEDarchiver(R) [life-critical clinical information system], and TPNstation(TM) [totally-automated parenteral nutrition] have and will greatly contribute to ease hospitals' growing pressures to improve patient safety, increase throughput and contain costs. Through the effective and efficient production of sterile, accurate, tamper-evident and ready-to-administer IVs, Health Robotics' solutions help hospitals eliminate life-threatening drug and diluent exchange errors, decrease other medical mistakes and sterility risks, work more efficiently, reduce waste and controlled substances' diversion, and diminish the gap between rising patient volume/acuity and scarce medical, nursing, and pharmacy staff. For more information, please visit: http://www.health-robotics.com
Advertisement
"Under the leadership of Fabio Fioravanti, Health Robotics' Chief Technical Officer, the SAC launches to a great start in 2011. We are all very grateful to Campus BioMedico University Hospital for hosting their SAC colleagues this year, and showcasing Health Robotics' products to the rest of SAC Board Members from University of Chicago, Ochsner Clinic, USC University Hospital, Sutter Health, Grifols, and Bolzano General Hospital, and finally to all of the participants in this week's events. Amongst the SAC highlights include the scientific review of gravimetric control processes, USP797 and cGMP regulations, negative and positive pressure chambers for robotic IV compounding, accuracy of QS doses, prevention of cross-contamination, and finally "hands-on" and peer-reviewed sessions on CytoCare, i.v.STATION, i.v.SOFT, i.v.STATION ONCO, and TPNstation," stated Gaspar DeViedma, Health Robotics' Executive Vice President.
Advertisement
The role of the Scientific Advisory Board is to assist Health Robotics' Research and Development efforts to complete its revolutionary I.V. Room of the Future concept: a "Patient-Aware, All-Digital" construct depicting a common visual and operational framework that elevates the overall understanding of the patients' I.V. Medication needs - its clinical, logistics, quality, costs, and procedural structures; the real-time tracking of I.V. Medications across the care continuum; the optimization of robotics and software automation tools to bridge the gap between rising patient volume/acuity and scarce pharmacy personnel resources; and finally the procedural discipline through visible steps and/or check-points that ensure that critical steps are taken, quality procedures are followed, and audit trails are generated as a by-product of the IV Admixture process.
About Health Robotics:
Founded in 2006, Health Robotics is the undisputed global leading supplier of life-critical intravenous medication robots, providing over 180 hospital installations in 6 continents with robotics-based technology and software automation solutions deployed utilizing virtual high-availability technology. Its world-leading solutions CytoCare(R) and i.v.STATION(R) ONCO [hazardous IVs], i.v.STATION(R) [non-hazardous IVs], i.v.SOFT(R) [workflow engine for manual compounding], MEDarchiver(R) [life-critical clinical information system], and TPNstation(TM) [totally-automated parenteral nutrition] have and will greatly contribute to ease hospitals' growing pressures to improve patient safety, increase throughput and contain costs. Through the effective and efficient production of sterile, accurate, tamper-evident and ready-to-administer IVs, Health Robotics' solutions help hospitals eliminate life-threatening drug and diluent exchange errors, decrease other medical mistakes and sterility risks, work more efficiently, reduce waste and controlled substances' diversion, and diminish the gap between rising patient volume/acuity and scarce medical, nursing, and pharmacy staff. For more information, please visit: http://www.health-robotics.com
For additional information, please contact:
Claudia Flaim, Marketing Coordinator
[email protected]
Phone: +39-0471-200-372
SOURCE Health Robotics